Prelude Therapeutics To Participate in Two Upcoming Healthcare Investor Conferences
February 09, 2023 09:05 ET
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the company will...